Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

590 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expression of activated integrin β7 in multiple myeloma patients.
Hosen N, Yoshihara S, Takamatsu H, Ri M, Nagata Y, Kosugi H, Shimomura Y, Hanamura I, Fuji S, Minauchi K, Kuroda J, Suzuki R, Nishimura N, Uoshima N, Nakamae H, Kawano Y, Mizuno I, Gomyo H, Suzuki K, Ozaki S, Nakamura S, Imai Y, Kizaki M, Negoro E, Handa H, Iida S. Hosen N, et al. Among authors: takamatsu h. Int J Hematol. 2021 Jul;114(1):3-7. doi: 10.1007/s12185-021-03162-2. Epub 2021 May 17. Int J Hematol. 2021. PMID: 33999338
Treatment of acute myeloid leukemia and myelodysplastic syndrome with orally administered cytarabine ocfosfate and granulocyte colony-stimulating factor.
Okumura H, Yoshida T, Takamatsu H, Katoh T, Murashima M, Watanabe A, Yamauchi H, Matano S, Chuhjo T, Takeshima M, Kaya H, Ohtake S, Nakamura S, Matsuda T. Okumura H, et al. Among authors: takamatsu h. Int J Hematol. 1997 Apr;65(3):263-8. doi: 10.1016/s0925-5710(96)00572-5. Int J Hematol. 1997. PMID: 9114597 Clinical Trial.
CD8-depleted donor leukocyte transfusions for cytomegalovirus antigenemia in patient with acute lymphoblastic leukemia treated with allogeneic CD34(+) cell transplantation.
Okumura H, Yoshida T, Takamatsu H, Mochizuki Y, Takeshima M, Ohtake S, Ikeno T, Nakamura S, Nakao S. Okumura H, et al. Among authors: takamatsu h. Am J Hematol. 2000 Dec;65(4):278-80. doi: 10.1002/1096-8652(200012)65:4<278::aid-ajh2>3.0.co;2-3. Am J Hematol. 2000. PMID: 11074552 Free article.
Detection of minimal residual disease in patients with multiple myeloma using clonotype-specific PCR primers designed from DNA extracted from archival bone marrow slides.
Takamatsu H, Ogawa Y, Kobayashi N, Obata K, Narisawa T, Nakayama K, Munemoto S, Aoki G, Ohata K, Kumano Y, Ozaki J, Murata R, Kondo Y, Terasaki Y, Kurokawa T, Miyamoto T, Shimizu N, Fukushima T, Yoshida A, Ueda T, Yoshida T, Nakao S. Takamatsu H, et al. Exp Hematol. 2013 Oct;41(10):894-902. doi: 10.1016/j.exphem.2013.05.004. Epub 2013 May 30. Exp Hematol. 2013. PMID: 23727584 Free article.
t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs.
Narita T, Inagaki A, Kobayashi T, Kuroda Y, Fukushima T, Nezu M, Fuchida S, Sakai H, Sekiguchi N, Sugiura I, Maeda Y, Takamatsu H, Tsukamoto N, Maruyama D, Kubota Y, Kojima M, Sunami K, Ono T, Ri M, Tobinai K, Iida S. Narita T, et al. Among authors: takamatsu h. Blood Cancer J. 2015 Feb 27;5(2):e285. doi: 10.1038/bcj.2015.6. Blood Cancer J. 2015. PMID: 25723856 Free PMC article. No abstract available.
590 results